D-1309-2019 Class I Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- May 29, 2019
- Initiation Date
- May 11, 2019
- Termination Date
- November 28, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 792 cartons
Product Description
Promacta (eltrombopag) 12.5 mg for Oral Suspension, Rx Only Manufactured by: Halo Pharmaceuticals, Inc. Whippany, New Jersey 07981 Distributed by: Novartis Pharmaceuticals Corporation East Hanover, NJ 07936 Product of Ireland, NDC 0078-0972-61.
Reason for Recall
Cross Contamination with Other Products: product is being recalled due to possible cross-contamination with peanut flour.
Distribution Pattern
Nationwide with in the United States
Code Information
Lot #: 8H57901589, Exp. 09/2020; 9H57900189 and 9H57900289, Exp. 12/2020.